Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study
University of Siena · Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · +19 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
435
total citations
- FWCI
- 56.05
- Percentile
- 100%
- References
- 25
Citations per year
Authors
17Topics & keywords
Topics
Keywords
- Medicine
- Microsatellite instability
- Pembrolizumab
- DNA mismatch repair
- Oncology
- Internal medicine
- Microsatellite
- Cancer
No related works found for this paper.